Skip to main content
Fig. 6 | Breast Cancer Research

Fig. 6

From: MiR-7 reduces the BCSC subset by inhibiting XIST to modulate the miR-92b/Slug/ESA axis and inhibit tumor growth

Fig. 6

MiR-7 agomir reduces BCSC-driven xenograft growth. a Representative images show the BCSC xenograft growth in NOD/SCID mice 21 days after treatment with Ad+Cy, miR-7 agomir, or PBS. b Mouse weight changes. c Tumor dynamic growth plot. d Tumor sizes 21 days after treatment. e Quantification of tumor sizes. f–i FCM analysis of CD44+CD24− and CD44+CD24−ESA+ BCSC percentages. j, k Western blotting analysis of CD44, RELA, Slug, and ESA expression levels in tumor tissues

Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us